InnaPhase Announces The Global Release of Newton and Galileo LIMS
InnaPhase announced the global release of Newton LIMS, a solution for pharmaceutical development, quality control, stability and environmental monitoring. The official release date of December 28, 2003 is in keeping with the Newton LIMS schedule unveiled at The 2003 Pittsburgh Conference. This is the third technology solution within the Pharma LIMS Suite which also includes Watson LIMS for bioanalysis and Galileo LIMS for in-vitro testing.
“The world’s major pharmaceutical companies have relied on our Watson LIMS solution for many years for their bioanalytical work,” said Dr. Jo Webber, President and CEO InnaPhase Corporation. “InnaPhase is tremendously excited to now provide our customers with a dedicated LIMS solution to take them through the analytical development phases and into manufacturing quality control and stability. Built upon a multi-tier architecture using robust, industry wide accepted technologies such as XML and Web Services to address pharmaceutical business needs, Newton will provide scalability, reliability, and legacy compatibility; thereby decreasing total-cost-of-ownership for pharmaceutical organizations.”
